Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Investment bank Piper Sandler announced a downgrade of Lenz Therapeutics, a biotechnology company, from "Overweight" to "Neutral".

Investment bank Piper Sandler announced a downgrade of Lenz Therapeutics, a biotechnology company, from "Overweight" to "Neutral".

老虎证券老虎证券2026/05/12 02:40
Show original
At the same time, the institution significantly cut its target stock price for the company, reducing it sharply from the previous $39 to $12.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!